National and Kapodistrian University of Athens
Μελέτη μεταγραφικών παραγόντων σε αιματολογικές κακοήθειες: εμπλοκή των IRF-1, GATA-1 και TLR-4 στην παθογένεια των μυελοδυσπλαστικών συνδρόμων
Abstract
dc:descriptionThe myelodysplastic syndrome (MDS) is an heterogeneous family of clonal disorders of the hematopoietic stem cell. Morphologically, it is characterized by dysplasia in at least one myeloid cell lineage. Typically the bone marrow is hypercellular as opposed to the cytopenias observed in the peripheral blood. The cause of cytopenias, in at least one subset of MDS patients, has been attributed to an excessive cytokineinduced intramedullary apoptotic death. MDS patients are anemic and frequently transfusion-dependent, due to ineffective erythropoiesis. The levels of several cytokines or ligands, known to have pro-apoptotic and inflammatory properties such as IL-1β, TNF and Fas-ligand, are elevated in myelodysplastic bone marrow (BM). This elevated expression has been implicated in increased apoptosis and inhibition of hematopoiesis. It has been hypothesized that TNF primes BM CD34+ cells for Fas-induced apoptosis, suggesting a Fas-FasL interaction as a possible pathogenetic mechanism contributing to immune destruction of CD34+ cells in human myelodysplasia. Furthermore, genetic alternations have been implicated in molecular pathway leading to disease appearance. Several transcription factors that their expression is altered in myelodysplastic syndromes have been studied in deepth over the past years. Activities of IRF-1 encompas maturation of cells, mediating immune responses and regulation of early events governing myeloid cells’ terminal differentiation. Deletions and somatic mutations of IRF-1 gene have been implicated in the multiphase process of human myelodysplasia and leukemic evolution. In addition, alternative mRNA splicing resulting in functional inactivation of IRF-1 has been reported to be involved in the development of the myelodysplastic phenotype. We evaluated any correlation between alternative splicing of IRF-1 mRNA and disease severity. In all MDS patients we detected the presence of the spliced isoforms whereas the full-length transcript was detected in 26 out of 45 patients. The exclusive presence of the alternative transcripts in the MDS patients links IRF-1 with the pathophysiological mechanism driving myelodysplasia and could be used as a diagnostic marker since the SLE with bone marrow alternation did not presented alternative splicing. The similar levels of IRF-1 transcription in both patients and controls, suggest that the IRF-1 gene regulation remains intact and the same as in the control cell s. The identical expression pattern of IRF-1 in BMMC, in CD34+ cells and in CD71+, erythroid cells suggests that the IRF-1 differential expression plausible reflects a molecular mechanism present not only in the differentiated compartment but also in the progenitor cells. In three samples that presented more than one IRF-1 transcripts besides the full-length transcript, we detect the presences of different nucleonic changes in exon 1. This could be attributed to the existence of subclonal populations that along with the normal cells contribute to the hematopoiesis process. Two alternative protein transcripts with 47kDa and 45kDa molecular weight were detected in MDS BMMC. This is the first time that alternative proteins are detected. IRF-1 is the sole inducer of iNOS expression following TNF or/and IFN-γ stimulation. The MDS patients that presented the full-length transcript maintained their ability to induce the expression of iNOS gene whereas the MDS patients that presented only truncated transcript did not, suggesting that only the full-length transcript is capable for the induction of the IRF-1 regulated genes.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2007
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Maratheftis, Christos
- Μαραθεύτης, Χρίστος
Subjects
dc:subject × 20- Μυελοδυσπλαστικά σύνδρομα (MDS)
- Μεταγραφικοί παράγοντες
- Απόπτωση
- Μεταγραφικός παράγοντας GATA-1
- Παράγοντας ρύθμισης των ιντερφερόνων - 1 (IRF-1)
- Υποδοχείς που ομοιάζουν με τον υποδοχέα Toll
- Αννεξίνη-II
- Επαγώμενη συνθετάση του νιτρικού οξέος (iNOS)
- Myelodysplastic syndromes
- Transcription factors
- Apoptosis
- GATA-1 transcription factor
- Inteferon regulatory factor -1 (IRF-1)
- Toll-like receptors
- Annexin-II
- Nitric oxide synthase indusible (iNOS)
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/18331